Showing results (101-110 of 4,366) with videos related to
Sort By:
Pageof 437
Clinical Immunology (Orlando, Fla.)|August 30, 2011
Analysis of bulk and virus-specific CD8+ T cells reveals advanced differentiation of CD8+ T cells in patients with common variable immunodeficiencyMartin Kuntz, Sigune Goldacker, Hubert E Blum, et al.Clinical Immunology (Orlando, Fla.)|July 12, 2011
Dalfampridine in multiple sclerosis: from symptomatic treatment to immunomodulationCarmen Espejo, Xavier MontalbanClinical Immunology (Orlando, Fla.)|September 17, 2011
Anti-FcεR1 antibody injections activate basophils and mast cells and delay Type 1 diabetes onset in NOD miceMarc P Hübner, David Larson, Marina N Torrero, et al.Clinical Immunology (Orlando, Fla.)|August 16, 2011
Immunopathogenesis of ischemia/reperfusion-associated tissue damageAntonis Ioannou, Jurandir Dalle Lucca, George C TsokosClinical Immunology (Orlando, Fla.)|March 17, 2011
Intravenous immunoglobulin modulates the maturation of TLR 4-primed peripheral blood monocytesMark Ballow, Cheryl AllenClinical Immunology (Orlando, Fla.)|May 14, 2011
Thymic microenvironment reconstitution after postnatal human thymus transplantationBin Li, Jie Li, Blythe H Devlin, et al.Clinical Immunology (Orlando, Fla.)|June 15, 2011
Fingolimod in multiple sclerosis: mechanisms of action and clinical efficacyJens Ingwersen, Orhan Aktas, Patrick Kuery, et al.Clinical Immunology (Orlando, Fla.)|May 7, 2011
Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1/YKL-40) specifically activates Akt signaling pathway in colonic epithelial cellsChun-Chuan Chen, Victoria Llado, Katrin Eurich, et al.Clinical Immunology (Orlando, Fla.)|March 19, 2011
Fumaric acid and its esters: an emerging treatment for multiple sclerosis with antioxidative mechanism of actionR Gold, R A Linker, M StangelClinical Immunology (Orlando, Fla.)|April 15, 2011
Myelin-reactive antibodies mediate the pathology of MBP-PLP fusion protein MP4-induced EAEStefanie Kuerten, Robert Pauly, Andrea Rottlaender, et al.Pageof 437